Postpartum Anticoagulation Guidelines for Patients with Nephrotic‑Range Proteinuria

Risk Assessment and Guideline Recommendation

The American College of Chest Physicians recommends extending thromboprophylaxis to 6 weeks after delivery for high‑risk postpartum patients whose significant risk factors (e.g., nephrotic‑range proteinuria) persist after birth【1】.

Low‑molecular‑weight heparin (enoxaparin) is the preferred agent in the postpartum period because it offers superior bioavailability, a longer half‑life, more predictable anticoagulation, a lower bleeding risk, and reduced incidence of heparin‑induced thrombocytopenia and osteopenia compared with unfractionated heparin【2】.
Standard prophylactic regimen: enoxaparin 40 mg subcutaneously once daily for a total of 6 weeks【3】.
Obese patients (Class III obesity): intermediate‑dose enoxaparin 40 mg subcutaneously every 12 hours or weight‑based dosing of 0.5 mg/kg subcutaneously every 12 hours【2】.
Warfarin alternative: target INR 2.0–3.0 for 6 weeks, with initial LMWH or UFH overlap until INR reaches 2.0【3】.

Prophylactic‑dose enoxaparin (40 mg daily): may be initiated ≥4 hours after removal of a neuraxial catheter, but no earlier than 12 hours after the block was performed【2】.
Intermediate‑dose enoxaparin (40 mg q12 h): may be started ≥4 hours after catheter removal, but no earlier than 24 hours after the block was performed【2】.

Anticoagulation should be continued for a minimum of 6 weeks postpartum, reflecting the period of highest venous thromboembolism (VTE) risk and the persistence of hypercoagulability in nephrotic syndrome【3】【5】.

Clinicians should monitor for VTE signs (e.g., unilateral leg swelling, chest pain, dyspnea) throughout the prophylaxis period【3】.

Sequential compression devices should be applied pre‑operatively to all patients undergoing cesarean delivery【2】.
For patients deemed very high‑risk, combine prophylactic LMWH with elastic stockings and/or intermittent pneumatic compression【5】.

If renal function declines, switch to unfractionated heparin (UFH) because it is cleared by the reticulo‑endothelial system rather than renally and has a short half‑life (60–90 minutes)【2】.
UFH dosing recommendation: 5,000 units subcutaneously every 8–12 hours postpartum【2】.